Strattera

Strattera, containing atomoxetine, is a non-stimulant medication approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in both children and adults. Unlike traditional stimulant medications, Strattera works by selectively inhibiting the reuptake of norepinephrine, helping to increase attention and reduce impulsivity without the potential for abuse. This makes it a suitable option for individuals who may be sensitive to stimulants or have a history of substance use disorders. Common side effects include fatigue, stomach upset, and changes in mood, necessitating regular monitoring by healthcare professionals.